|
|
| Close | Print |
31/01/2008, 2008, 08.01 AM CET
|
| Novartis files its Form 20-F annual report with the US Securities and Exchange Commission |
Basel, January 31, 2008 - Novartis has filed its annual report on Form 20-F with the US Securities and Exchange Commission and has posted this document on its website at www.novartis.com. A copy of the Group's traditional annual report is also available on this website. Novartis shareholders may receive a hard copy of either of these documents, each of which contain complete audited financial statements, free of charge, upon request.
Basel, January 31, 2008 - Novartis has filed its annual report on Form 20-F with the US Securities and Exchange Commission and has posted this document on its website at www.novartis.com. A copy of the Group's traditional annual report is also available on this website. Novartis shareholders may receive a hard copy of either of these documents, each of which contain complete audited financial statements, free of charge, upon request.
# # #
Novartis Media Relations
|
John Gilardi
Novartis Global Media Relations
+41 61 324 3018 (direct)
+41 79 596 1408 (mobile)
|
Brandi Robinson
Novartis US Corporate Communications
+1 212 830 2408 (direct)
+1 212 361 9368 (mobile)
|
Novartis Investor Relations
|
International |
North America |
|
Ruth Metzler-Arnold
Katharina Ambuehl
Pierre-Michel Bringer
Jason Hannon
Thomas Hungerbuehler
Richard Jarvis
Isabella Zinck
Central phone no: +41 61 324 7944
|
Jill Pozarek +1 212 830 2445
Edwin Valeriano +1 212 830 2456
|
Attachments:
Media release (PDF)
|
|
|
The information in the press releases on these pages was factually accurate on the date of publication. These press releases remain on Novartis' website for historical purposes only. Novartis assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.
|
|
|